Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Antiviral activity of the long chain pentraxin PTX3 against influenza viruses.

Reading PC, Bozza S, Gilbertson B, Tate M, Moretti S, Job ER, Crouch EC, Brooks AG, Brown LE, Bottazzi B, Romani L, Mantovani A.

J Immunol. 2008 Mar 1;180(5):3391-8.

2.

A single amino acid substitution in the hemagglutinin of H3N2 subtype influenza A viruses is associated with resistance to the long pentraxin PTX3 and enhanced virulence in mice.

Job ER, Bottazzi B, Short KR, Deng YM, Mantovani A, Brooks AG, Reading PC.

J Immunol. 2014 Jan 1;192(1):271-81. doi: 10.4049/jimmunol.1301814. Epub 2013 Dec 4.

3.

Pandemic H1N1 influenza A viruses are resistant to the antiviral activities of innate immune proteins of the collectin and pentraxin superfamilies.

Job ER, Deng YM, Tate MD, Bottazzi B, Crouch EC, Dean MM, Mantovani A, Brooks AG, Reading PC.

J Immunol. 2010 Oct 1;185(7):4284-91. doi: 10.4049/jimmunol.1001613. Epub 2010 Sep 3.

4.

Serum amyloid P is a sialylated glycoprotein inhibitor of influenza A viruses.

Job ER, Bottazzi B, Gilbertson B, Edenborough KM, Brown LE, Mantovani A, Brooks AG, Reading PC.

PLoS One. 2013;8(3):e59623. doi: 10.1371/journal.pone.0059623. Epub 2013 Mar 27.

5.
6.

Mouse Saliva Inhibits Transit of Influenza Virus to the Lower Respiratory Tract by Efficiently Blocking Influenza Virus Neuraminidase Activity.

Gilbertson B, Ng WC, Crawford S, McKimm-Breschkin JL, Brown LE.

J Virol. 2017 Jun 26;91(14). pii: e00145-17. doi: 10.1128/JVI.00145-17. Print 2017 Jul 15.

7.

Human H-ficolin inhibits replication of seasonal and pandemic influenza A viruses.

Verma A, White M, Vathipadiekal V, Tripathi S, Mbianda J, Ieong M, Qi L, Taubenberger JK, Takahashi K, Jensenius JC, Thiel S, Hartshorn KL.

J Immunol. 2012 Sep 1;189(5):2478-87. doi: 10.4049/jimmunol.1103786. Epub 2012 Jul 30.

8.

Computationally Optimized Broadly Reactive Hemagglutinin Elicits Hemagglutination Inhibition Antibodies against a Panel of H3N2 Influenza Virus Cocirculating Variants.

Wong TM, Allen JD, Bebin-Blackwell AG, Carter DM, Alefantis T, DiNapoli J, Kleanthous H, Ross TM.

J Virol. 2017 Nov 30;91(24). pii: e01581-17. doi: 10.1128/JVI.01581-17. Print 2017 Dec 15.

9.

Inactivated H7 Influenza Virus Vaccines Protect Mice despite Inducing Only Low Levels of Neutralizing Antibodies.

Kamal RP, Blanchfield K, Belser JA, Music N, Tzeng WP, Holiday C, Burroughs A, Sun X, Maines TR, Levine MZ, York IA.

J Virol. 2017 Sep 27;91(20). pii: e01202-17. doi: 10.1128/JVI.01202-17. Print 2017 Oct 15.

10.

An H1-H3 chimeric influenza virosome confers complete protection against lethal challenge with PR8 (H1N1) and X47 (H3N2) viruses in mice.

Abdoli A, Soleimanjahi H, Tavassoti Kheiri M, Jamali A, Mazaheri V, Abdollahpour Alitappeh M.

Pathog Dis. 2014 Dec;72(3):197-207. doi: 10.1111/2049-632X.12206. Epub 2014 Sep 1.

PMID:
25066138
11.

The Proteolytic Activation of (H3N2) Influenza A Virus Hemagglutinin Is Facilitated by Different Type II Transmembrane Serine Proteases.

Kühn N, Bergmann S, Kösterke N, Lambertz RLO, Keppner A, van den Brand JMA, Pöhlmann S, Weiß S, Hummler E, Hatesuer B, Schughart K.

J Virol. 2016 Apr 14;90(9):4298-4307. doi: 10.1128/JVI.02693-15. Print 2016 May.

12.

Serum amyloid P component binds to influenza A virus haemagglutinin and inhibits the virus infection in vitro.

Andersen O, Vilsgaard Ravn K, Juul Sørensen I, Jonson G, Holm Nielsen E, Svehag SE.

Scand J Immunol. 1997 Oct;46(4):331-7.

13.

CLEC5A-Mediated Enhancement of the Inflammatory Response in Myeloid Cells Contributes to Influenza Virus Pathogenicity In Vivo.

Teng O, Chen ST, Hsu TL, Sia SF, Cole S, Valkenburg SA, Hsu TY, Zheng JT, Tu W, Bruzzone R, Peiris JSM, Hsieh SL, Yen HL.

J Virol. 2016 Dec 16;91(1). pii: e01813-16. doi: 10.1128/JVI.01813-16. Print 2017 Jan 1.

14.

Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses.

Liu WC, Lin CY, Tsou YT, Jan JT, Wu SC.

J Virol. 2015 Jul;89(14):7224-34. doi: 10.1128/JVI.00585-15. Epub 2015 May 6.

15.

Mechanisms of the action of povidone-iodine against human and avian influenza A viruses: its effects on hemagglutination and sialidase activities.

Sriwilaijaroen N, Wilairat P, Hiramatsu H, Takahashi T, Suzuki T, Ito M, Ito Y, Tashiro M, Suzuki Y.

Virol J. 2009 Aug 13;6:124. doi: 10.1186/1743-422X-6-124.

16.

Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands Work Additively via MyD88 To Induce Protective Antiviral Immunity in Mice.

Goff PH, Hayashi T, He W, Yao S, Cottam HB, Tan GS, Crain B, Krammer F, Messer K, Pu M, Carson DA, Palese P, Corr M.

J Virol. 2017 Sep 12;91(19). pii: e01050-17. doi: 10.1128/JVI.01050-17. Print 2017 Oct 1.

17.

Cationic lipid/DNA complex-adjuvanted influenza A virus vaccination induces robust cross-protective immunity.

Hong DK, Chang S, Botham CM, Giffon TD, Fairman J, Lewis DB.

J Virol. 2010 Dec;84(24):12691-702. doi: 10.1128/JVI.00769-10. Epub 2010 Oct 13.

18.

Serum amyloid P component inhibits influenza A virus infections: in vitro and in vivo studies.

Horváth A, Andersen I, Junker K, Lyck Fogh-Schultz B, Holm Nielsen E, Gizurarson S, Andersen O, Kármán J, Rajnavölgyi E, Erdei A, Svehag SE.

Antiviral Res. 2001 Oct;52(1):43-53.

PMID:
11530187
19.

Collectin-mediated antiviral host defense of the lung: evidence from influenza virus infection of mice.

Reading PC, Morey LS, Crouch EC, Anders EM.

J Virol. 1997 Nov;71(11):8204-12.

20.

Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.

Walz L, Kays SK, Zimmer G, von Messling V.

J Virol. 2018 Aug 16;92(17). pii: e01006-18. doi: 10.1128/JVI.01006-18. Print 2018 Sep 1.

Supplemental Content

Support Center